Market cap
₹2 Cr
Revenue (TTM)
₹1 Cr
P/E Ratio
--
P/B Ratio
1.1
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹-39 Cr
-
ROE
-187.8 %
-
ROCE
-187.8 %
-
Industry P/E
419.92
-
EV/EBITDA
-13.3
-
Debt to Equity
0
-
Book Value
₹--
-
EPS
₹-0
-
Face value
10
-
Shares outstanding
32,002,700
10 Years Aggregate
CFO
₹-1.66 Cr
EBITDA
₹-28.90 Cr
Net Profit
₹-32.37 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Socrus Bio Sciences
| -44.0 | -- | -- | -69.1 | -50.9 | -46.0 | -21.9 |
|
BSE Sensex*
| -8.8 | 0.6 | 1.8 | -4.4 | 6.0 | 6.6 | 10.8 |
|
BSE Healthcare#
| 18.8 | 2.8 | 8.7 | 17.1 | 23.1 | 14.8 | 12.4 |
|
Company
|
2014
|
|---|---|
|
Socrus Bio Sciences
| 13.3 |
|
BSE Sensex
| 29.9 |
|
BSE Healthcare
| 47.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Socrus Bio Sciences
|
0.5 | 1.5 | 1.2 | -0.1 | -- | -- | -- | 1.1 |
| 15.9 | 68.5 | 44.6 | -16.6 | -- | 0 | -- | -- | |
| 174.8 | 2,746.1 | 2,901.5 | 16.2 | 4.7 | 0.3 | 169.9 | 0.4 | |
| 28.9 | 8.8 | 0.2 | 0.0 | 14.4 | 0.5 | 419.9 | 2.2 | |
| 579.0 | 13,940.5 | 3,812.8 | 400.9 | 12.8 | 13.9 | 34.8 | 4.3 | |
| 74.8 | 269.2 | 137.7 | -9.4 | -8.1 | -9.2 | -- | 2.9 | |
| 329.7 | 14,931.8 | 3,171.8 | 521.3 | 19.3 | 18.1 | 28.9 | 4.7 | |
| 1,485.0 | 31,434.1 | 2,250.4 | 361.7 | 21.5 | 15.5 | 86.9 | 12.3 | |
| 16.1 | 240.8 | 84.6 | 12.8 | -2.1 | 20.8 | 18.8 | 7.5 | |
| 18.1 | 40.5 | 55.1 | -2.9 | 17.2 | -16.1 | -- | 0.4 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Socrus Bio Sciences
Wholesale of pharmaceutical and medical goods
-
Incorporated
1989
-
Chairman
Rajeev Agnihotri
-
Managing Director
Rajeev Agnihotri
-
Headquarters
Mumbai, Maharashtra
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Socrus Bio Sciences
What is the current share price of Socrus Bio Sciences Ltd Today?
The share price of Socrus Bio Sciences Ltd is ₹0.48 (BSE) as of 03-Aug-2015 IST. Socrus Bio Sciences Ltd has given a return of -50.88% in the last 3 years.
What is the current PB & PE ratio of Socrus Bio Sciences Ltd?
Since, TTM earnings of Socrus Bio Sciences Ltd is negative, P/E ratio is not available.
The P/B ratio of Socrus Bio Sciences Ltd is 1.10 times as on 03-Aug-2015, a 51 discount to its peers’ median range of 2.24 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2013 |
0.00 |
2.96 |
2012 |
3.11 |
0.39 |
2011 |
3.19 |
0.42 |
2009 |
42.43 |
0.25 |
2008 |
31.17 |
0.62 |
What is the 52 Week High and Low of Socrus Bio Sciences Ltd?
The 52-week high and low of Socrus Bio Sciences Ltd are Rs -- and Rs -- as of 30-Aug-2026.
What is the market cap of Socrus Bio Sciences Ltd?
Socrus Bio Sciences Ltd has a market capitalisation of ₹ 2 Cr as on 03-Aug-2015. As per SEBI classification, it is a company.
Should I invest in Socrus Bio Sciences Ltd?
Before investing in Socrus Bio Sciences Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.